WithdrawnNot Applicable

Motor Deficits and Signal Conduction in Individuals With Williams Syndrome

Stopped: No participents enrolled

Israel0Started 2023-02

Plain-language summary

The current study aims to validate basic research findings of abnormal conductivity and motor abilities from a mouse model in humans. The study will measure nerve conduction properties in WS individuals and characterize motor symptoms in individuals with WS.

Who can participate

Age range3 Years – 30 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * WS patients. Exclusion Criteria: * WS patients suffering from additional neurological condition (such as epilepsy). * Participants who will have difficulties preforming the tests may ask to be excluded.

What they're measuring

Nerve conduction test - Amplitude

Timeframe: 30 days

Nerve conduction test - Latency

Timeframe: 30 days

Trial details

NCT IDNCT05430763

SponsorSheba Medical Center

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2030-08

View on ClinicalTrials.gov More Williams Syndrome trials